Terms ending in 2029
Every in-force patent on Array Biopharma Inc.'s record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,329,709 | 5H-CYCLOPENTA[D]PYRIMIDINES as Akt Protein Kinase Inhibitors In force · High confidence | Array Biopharma Inc. | In force | High confidence | |
| US 9,328,091 | 5H-CYCLOPENTA[d]PYRIMIDINES AS AKT PROTEIN KINASE INHIBITORS In force · High confidence | Array Biopharma, Inc. | In force | High confidence | |
| US 8,202,899 | Pyrazole Urea Derivatives Used as Kinase Inhibitors In force · High confidence | Array Biopharma, Inc. | In force | High confidence | |
| US 11,813,246 | Pharmaceutical Composition In force · Medium confidence | Alexion Pharma International Operations Limited | In force | Medium confidence | |
| US 12,220,403 | Pharmaceutical Composition In force · Low confidence | Alexion Pharma International Operations Limited | In force | Low confidence | |
| US 12,318,367 | Pharmaceutical Composition In force · Low confidence | Alexion Pharma International Operations Limited | In force | Low confidence | |
| US 12,364,684 | Pharmaceutical Composition In force · Low confidence | Alexion Pharma International Operations Limited | In force | Low confidence | |
| US 8,895,566 | 5H-CYCLOPENTA[D]PYRIMIDINES as Akt Protein Kinase Inhibitors In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 7,425,637 | N3 Alkylated Benzimidazole Derivatives as Mek Inhibitors In force · High confidence | Alexion Pharma International Operations Limited | In force | High confidence | |
| US 8,178,131 | Pyrrolopyridines as Kinase Inhibitors In force · High confidence | Array Biopharma, Inc. | In force | High confidence | |
| 19 more term ends in 2029 · Pro | |||||
10 of 29 patents shown. Soonest term end first, then patent number.
Pro members see all 29.
21 of these are in force and held by Array Biopharma Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.